Advertisement
Screener

FULCRUM THERAPEUTICS, INC. (FULC) Auditor

FULCRUM THERAPEUTICS, INC. Auditor

The independent registered public accounting firm that signed the audit report in each annual report on Form 10-K, newest first. PCAOB firm ID and the internal-control attestation are as tagged on the cover from fiscal 2021; earlier rows come from the signed report text.

  • 2026-02-24: Fiscal year end 2025-12-31; Auditor Ernst & Young LLP; PCAOB firm ID 42; Location Boston, Massachusetts.
  • 2025-02-25: Fiscal year end 2024-12-31; Auditor Ernst & Young LLP; PCAOB firm ID 42; Location Boston, Massachusetts.
  • 2024-02-27: Fiscal year end 2023-12-31; Auditor Ernst & Young LLP; PCAOB firm ID 42; Location Boston, Massachusetts.
  • 2023-06-26: Fiscal year end 2022-12-31; Auditor Ernst & Young LLP; PCAOB firm ID 42; Location Boston, Massachusetts.
FiledFiscal year endAuditorPCAOB firm IDLocationInternal-control attestation
2026-02-242025-12-31Ernst & Young LLP42Boston, MassachusettsNo
2025-02-252024-12-31Ernst & Young LLP42Boston, MassachusettsNo
2024-02-272023-12-31Ernst & Young LLP42Boston, MassachusettsNo
2023-06-262022-12-31Ernst & Young LLP42Boston, MassachusettsNo
2023-06-262021-12-31Ernst & Young LLP42Boston, MassachusettsNo
2023-06-232020-12-31Ernst & Young LLPBoston, MassachusettsNo
2023-03-092022-12-31Ernst & Young LLP42Boston, MassachusettsNo
2022-03-032021-12-31Ernst & Young LLP42Boston, MassachusettsNo
2021-03-042020-12-31Ernst & Young LLPBoston, MassachusettsNo
2020-03-052019-12-31Ernst & Young LLPBoston, Massachusetts

Similar stocks

Stock NameCountryMarket CapPE Ratio
Contineum Therapeutics, Inc. (CTNM)United States$0.289B-4.40
Perspective Therapeutics, Inc. (CATX)United States$0.284B-3.34
Upstream Bio, Inc. (UPB)United States$0.284B-2.42
ROCKET PHARMACEUTICALS, INC. (RCKT)United States$0.296B-21.78
STANDARD BIOTOOLS INC. (LAB)United States$0.297B3.80
Sagimet Biosciences Inc. (SGMT)United States$0.279B
Vanda Pharmaceuticals Inc. (VNDA)United States$0.302B-1.35
GT Biopharma, Inc. (GTBP)United States$0.309B-4.58
Mereo BioPharma Group plc (MREO)$0.269B-9.41
Greenwich LifeSciences, Inc. (GLSI)United States$0.267B-15.02